[Relation of monoamines to mental disorders].
D000588:Amines / Q000378:metabolism*; D000818:Animals; D001714:Bipolar Disorder / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D002490:Central Nervous System / Q000187:drug effects; D003863:Depression / Q000139:chemically induced / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D004837:Epinephrine / Q000378:metabolism; D006213:Hallucinogens / Q000378:metabolism*; D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000009:adverse effects; D001523:Mental Disorders / Q000378:metabolism*; D008745:Methylation; D008996:Monoamine Oxidase Inhibitors / Q000378:metabolism; D010627:Phenethylamines / Q000009:adverse effects; D011562:Psilocybin / Q000378:metabolism; D012110:Reserpine / Q000378:metabolism; D012559:Schizophrenia / Q000139:chemically induced; D012701:Serotonin / Q000378:metabolism; D014363:Tryptamines / Q000378:metabolism
D000588:Amines; D002395:Catecholamines; D006213:Hallucinogens; D008996:Monoamine Oxidase Inhibitors; D010627:Phenethylamines; D014363:Tryptamines; D011562:Psilocybin; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D008238:Lysergic Acid Diethylamide; D004298:Dopamine; D004837:Epinephrine
Vztah monoaminů k psychickým poruchám.